Publications of R. Rupprecht
All genres
Journal Article (107)
1.
Journal Article
67, p. E324 - E324 (2019)
Astrocytes prime an early synaptic pruning and remodelling in the prefrontal cortex upon antidepressant treatment. GLIA 2.
Journal Article
19 (6), 1740 (2018)
Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 3.
Journal Article
105, pp. 154 - 163 (2016)
Desipramine targets astrocytes to attenuate synaptic plasticity via modulation of the ephrinA3/EphA4 signalling. NEUROPHARMACOLOGY 4.
Journal Article
10 (8), pp. 1061 - 1065 (2015)
Sexual motivation is reflected by stimulus-dependent motor cortex excitability. SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE 5.
Journal Article
36 (6), pp. 2374 - 2386 (2015)
Connectivity and Functional Profiling of Abnormal Brain Structures in Pedophilia. HUMAN BRAIN MAPPING 6.
Journal Article
17 (6), pp. 833 - 843 (2014)
Amygdalohippocampal neuroplastic changes following neuroleptic treatment with quetiapine in first-episode schizophrenia. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 7.
Journal Article
53, pp. 76 - 83 (2014)
The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: A randomized trial. JOURNAL OF PSYCHIATRIC RESEARCH 8.
Journal Article
39, pp. 141 - 151 (2014)
Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression. PSYCHONEUROENDOCRINOLOGY 9.
Journal Article
14 (11), pp. 1329 - 1335 (2013)
Talking to the Synapse: How Antidepressants Can Target Glial Cells to Reshape Brain Circuits. CURRENT DRUG TARGETS 10.
Journal Article
16 (6), pp. 1361 - 1371 (2013)
Lipid raft integrity affects GABA(A) receptor, but not NMDA receptor modulation by psychopharmacological compounds. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 11.
Journal Article
232, pp. 161 - 168 (2013)
ACUTE ANTIDEPRESSANT TREATMENT DIFFERENTLY MODULATES ERK/MAPK ACTIVATION IN NEURONS AND ASTROCYTES OF THE ADULT MOUSE PREFRONTAL CORTEX. NEUROSCIENCE 12.
Journal Article
11 (2), pp. 171 - 185 (2013)
Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases. CURRENT NEUROPHARMACOLOGY 13.
Journal Article
262, pp. S107 - S112 (2012)
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 14.
Journal Article
159B (3), pp. 310 - 315 (2012)
Lack of association of the 5-HT3A receptor with schizophrenia. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 15.
Journal Article
12 (4), pp. 360 - 370 (2012)
Recent Developments in Potential Anxiolytic Agents Targeting GABA(A)/BzR Complex or the Translocator Protein (18kDa) (TSPO). Current Topics in Medicinal Chemistry 16.
Journal Article
62 (1), pp. 209 - 216 (2012)
N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: A putative cellular mechanism for quetiapine as antidepressant. Neuropharmacology 17.
Journal Article
24 (1), pp. 71 - 81 (2012)
Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa. Journal of Neuroendocrinology 18.
Journal Article
24 (1), pp. 82 - 92 (2012)
Translocator Protein (18 kDa) as a Target for Novel Anxiolytics with a Favourable Side-Effect Profile. Journal of Neuroendocrinology 19.
Journal Article
72 (9), pp. 1242 - 1247 (2011)
Major Depressive Disorder is associated with cardiovascular risk factors and Low Omega-3 Index. Journal of Clinical Psychiatry 20.
Journal Article
44 (6), p. 288 - 288 (2011)
Astrocytes and neurons coordinate their responsiveness to antidepressant treatment to modulate synaptic plasticity. Pharmacopsychiatry